Adaptive Biotechnologies Corp Insider Trading for February 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Adaptive Biotechnologies Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Adaptive Biotechnologies Corp for February 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.55 | 14,675 | 96,121 | 255,325 | |
| Feb 26 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.55 | 15,000 | 98,250 | 270,000 | |
| Feb 26 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 57.33 | 599 | 34,341 | 0 | 599 to 0 (-100.00 %) |
| Feb 26 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 56.13 | 14,076 | 790,086 | 599 | 14.7 K to 599 (-95.92 %) |
| Feb 26 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.55 | 14,675 | 96,121 | 14,675 | 0 to 14.7 K |
| Feb 26 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 59.33 | 3,258 | 193,297 | 0 | 3.3 K to 0 (-100.00 %) |
| Feb 26 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 58.74 | 3,374 | 198,189 | 3,258 | 6.6 K to 3.3 K (-50.87 %) |
| Feb 26 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 57.12 | 4,134 | 236,134 | 6,632 | 10.8 K to 6.6 K (-38.40 %) |
| Feb 26 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 56.45 | 4,234 | 239,009 | 10,766 | 15 K to 10.8 K (-28.23 %) |
| Feb 26 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.55 | 15,000 | 98,250 | 15,000 | 0 to 15 K |
| Feb 24 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.55 | 15,000 | 98,250 | 255,000 | |
| Feb 24 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.55 | 15,000 | 98,250 | 270,000 | |
| Feb 24 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 56.04 | 7,039 | 394,466 | 0 | 7 K to 0 (-100.00 %) |
| Feb 24 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 55.54 | 4,461 | 247,764 | 7,039 | 11.5 K to 7 K (-38.79 %) |
| Feb 24 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 54.16 | 3,500 | 189,560 | 11,500 | 15 K to 11.5 K (-23.33 %) |
| Feb 24 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.55 | 15,000 | 98,250 | 15,000 | 0 to 15 K |
| Feb 24 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 62.20 | 656 | 40,803 | 0 | 656 to 0 (-100.00 %) |
| Feb 24 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 61.01 | 400 | 24,404 | 656 | 1.1 K to 656 (-37.88 %) |
| Feb 24 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 60.21 | 4,100 | 246,861 | 1,056 | 5.2 K to 1.1 K (-79.52 %) |
| Feb 24 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 59.28 | 9,844 | 583,552 | 5,156 | 15 K to 5.2 K (-65.63 %) |
| Feb 24 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.55 | 15,000 | 98,250 | 15,000 | 0 to 15 K |
| Feb 22 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.55 | 15,000 | 98,250 | 285,000 | |
| Feb 22 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 63.03 | 3,793 | 239,073 | 0 | 3.8 K to 0 (-100.00 %) |
| Feb 22 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 62.30 | 7,708 | 480,208 | 3,793 | 11.5 K to 3.8 K (-67.02 %) |
| Feb 22 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 61.47 | 3,499 | 215,084 | 11,501 | 15 K to 11.5 K (-23.33 %) |
| Feb 22 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.55 | 15,000 | 98,250 | 15,000 | 0 to 15 K |
| Feb 19 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.55 | 15,000 | 98,250 | 300,000 | |
| Feb 19 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.55 | 15,000 | 98,250 | 315,000 | |
| Feb 19 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 61.20 | 9,108 | 557,410 | 0 | 9.1 K to 0 (-100.00 %) |
| Feb 19 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 60.49 | 5,892 | 356,407 | 9,108 | 15 K to 9.1 K (-39.28 %) |
| Feb 19 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.55 | 15,000 | 98,250 | 15,000 | 0 to 15 K |
| Feb 19 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 62.28 | 9,799 | 610,282 | 0 | 9.8 K to 0 (-100.00 %) |
| Feb 19 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 61.63 | 5,201 | 320,538 | 9,799 | 15 K to 9.8 K (-34.67 %) |
| Feb 19 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.55 | 15,000 | 98,250 | 15,000 | 0 to 15 K |
| Feb 17 2021 | ADPT | Adaptive Biotechno ... | DOBMEIER ERIC | Director | Option Exercise | A | 66.50 | 3,759 | 249,974 | 3,759 | |
| Feb 17 2021 | ADPT | Adaptive Biotechno ... | DOBMEIER ERIC | Director | Grant | A | 0.00 | 1,504 | 0 | 1,504 | 0 to 1.5 K |
| Feb 17 2021 | ADPT | Adaptive Biotechno ... | LO FRANCIS | Chief People Office ... | Option Exercise | M | 7.80 | 2,000 | 15,600 | 157,000 | |
| Feb 17 2021 | ADPT | Adaptive Biotechno ... | LO FRANCIS | Chief People Office ... | Sell | S | 65.45 | 2,000 | 130,900 | 0 | 2 K to 0 (-100.00 %) |
| Feb 17 2021 | ADPT | Adaptive Biotechno ... | LO FRANCIS | Chief People Office ... | Buy | M | 7.80 | 2,000 | 15,600 | 2,000 | 0 to 2 K |
| Feb 17 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.55 | 15,000 | 98,250 | 330,000 | |
| Feb 17 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.55 | 15,000 | 98,250 | 345,000 | |
| Feb 17 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 65.31 | 13,301 | 868,688 | 0 | 13.3 K to 0 (-100.00 %) |
| Feb 17 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 64.78 | 1,699 | 110,061 | 13,301 | 15 K to 13.3 K (-11.33 %) |
| Feb 17 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.55 | 15,000 | 98,250 | 15,000 | 0 to 15 K |
| Feb 17 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 67.00 | 300 | 20,100 | 0 | 300 to 0 (-100.00 %) |
| Feb 17 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 66.38 | 9,621 | 638,642 | 300 | 9.9 K to 300 (-96.98 %) |
| Feb 17 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 65.55 | 3,130 | 205,172 | 9,921 | 13.1 K to 9.9 K (-23.98 %) |
| Feb 17 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 64.53 | 1,949 | 125,769 | 13,050 | 15 K to 13.1 K (-12.99 %) |
| Feb 17 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.55 | 15,000 | 98,250 | 15,000 | 0 to 15 K |
| Feb 17 2021 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Option Exercise | M | 31.71 | 16,250 | 515,288 | 48,750 | |
| Feb 17 2021 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Sell | S | 65.29 | 9,256 | 604,324 | 1,300 | 10.6 K to 1.3 K (-87.68 %) |
| Feb 17 2021 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Sell | S | 64.56 | 2,100 | 135,576 | 10,556 | 12.7 K to 10.6 K (-16.59 %) |
| Feb 17 2021 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Sell | S | 63.43 | 4,894 | 310,426 | 12,656 | 17.6 K to 12.7 K (-27.89 %) |
| Feb 17 2021 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Buy | M | 31.71 | 16,250 | 515,288 | 17,550 | 1.3 K to 17.6 K (+1,250.00 %) |
| Feb 17 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 31.71 | 16,250 | 515,288 | 48,750 | |
| Feb 17 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 65.29 | 9,528 | 622,083 | 0 | 9.5 K to 0 (-100.00 %) |
| Feb 17 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 64.59 | 1,700 | 109,803 | 9,528 | 11.2 K to 9.5 K (-15.14 %) |
| Feb 17 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 63.42 | 5,022 | 318,495 | 11,228 | 16.3 K to 11.2 K (-30.90 %) |
| Feb 17 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 31.71 | 16,250 | 515,288 | 16,250 | 0 to 16.3 K |
| Feb 17 2021 | ADPT | Adaptive Biotechno ... | NEUPERT PETER M | Director | Option Exercise | A | 66.50 | 3,759 | 249,974 | 3,759 | |
| Feb 17 2021 | ADPT | Adaptive Biotechno ... | NEUPERT PETER M | Director | Grant | A | 0.00 | 1,504 | 0 | 1,504 | 0 to 1.5 K |
| Feb 17 2021 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Option Exercise | M | 0.45 | 2,000 | 900 | 55,000 | |
| Feb 17 2021 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Option Exercise | A | 66.50 | 3,759 | 249,974 | 3,759 | |
| Feb 17 2021 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 65.45 | 2,000 | 130,900 | 1,504 | 3.5 K to 1.5 K (-57.08 %) |
| Feb 17 2021 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Buy | M | 0.45 | 2,000 | 900 | 3,504 | 1.5 K to 3.5 K (+132.98 %) |
| Feb 17 2021 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Grant | A | 0.00 | 1,504 | 0 | 1,504 | 0 to 1.5 K |
| Feb 17 2021 | ADPT | Adaptive Biotechno ... | Conroy Kevin T | Director | Option Exercise | A | 66.50 | 3,759 | 249,974 | 3,759 | |
| Feb 17 2021 | ADPT | Adaptive Biotechno ... | Conroy Kevin T | Director | Grant | A | 0.00 | 1,504 | 0 | 1,504 | 0 to 1.5 K |
| Feb 17 2021 | ADPT | Adaptive Biotechno ... | Pellini Michael J | Director | Option Exercise | A | 66.50 | 3,759 | 249,974 | 3,759 | |
| Feb 17 2021 | ADPT | Adaptive Biotechno ... | Pellini Michael J | Director | Grant | A | 0.00 | 1,504 | 0 | 1,504 | 0 to 1.5 K |
| Feb 17 2021 | ADPT | Adaptive Biotechno ... | GOEL DAVID E. | Director | Option Exercise | A | 66.50 | 3,759 | 249,974 | 3,759 | |
| Feb 17 2021 | ADPT | Adaptive Biotechno ... | GOEL DAVID E. | Director | Grant | A | 0.00 | 1,504 | 0 | 1,504 | 0 to 1.5 K |
| Feb 16 2021 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Option Exercise | M | 7.80 | 6,000 | 46,800 | 89,000 | |
| Feb 16 2021 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Option Exercise | A | 66.50 | 3,759 | 249,974 | 3,759 | |
| Feb 16 2021 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Sell | S | 65.08 | 6,000 | 390,480 | 1,504 | 7.5 K to 1.5 K (-79.96 %) |
| Feb 16 2021 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Buy | M | 7.80 | 6,000 | 46,800 | 7,504 | 1.5 K to 7.5 K (+398.94 %) |
| Feb 16 2021 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Grant | A | 0.00 | 1,504 | 0 | 1,504 | 0 to 1.5 K |
| Feb 12 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.55 | 15,000 | 98,250 | 360,000 | |
| Feb 12 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.55 | 15,000 | 98,250 | 375,000 | |
| Feb 12 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 63.67 | 4,271 | 271,935 | 0 | 4.3 K to 0 (-100.00 %) |
| Feb 12 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 63.12 | 10,729 | 677,214 | 4,271 | 15 K to 4.3 K (-71.53 %) |
| Feb 12 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.55 | 15,000 | 98,250 | 15,000 | 0 to 15 K |
| Feb 12 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 64.76 | 618 | 40,022 | 0 | 618 to 0 (-100.00 %) |
| Feb 12 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 64.09 | 3,798 | 243,414 | 618 | 4.4 K to 618 (-86.01 %) |
| Feb 12 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 63.00 | 3,814 | 240,282 | 4,416 | 8.2 K to 4.4 K (-46.34 %) |
| Feb 12 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 62.14 | 6,770 | 420,688 | 8,230 | 15 K to 8.2 K (-45.13 %) |
| Feb 12 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.55 | 15,000 | 98,250 | 15,000 | 0 to 15 K |
| Feb 10 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 64.27 | 1,200 | 77,124 | 1,709,780 | 1.7 M to 1.7 M (-0.07 %) |
| Feb 10 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 63.25 | 1,204 | 76,153 | 1,710,980 | 1.7 M to 1.7 M (-0.07 %) |
| Feb 10 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 62.56 | 6,801 | 425,471 | 1,712,184 | 1.7 M to 1.7 M (-0.40 %) |
| Feb 10 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 61.51 | 795 | 48,900 | 1,718,985 | 1.7 M to 1.7 M (-0.05 %) |
| Feb 10 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 63.23 | 4,160 | 263,037 | 1,719,780 | 1.7 M to 1.7 M (-0.24 %) |
| Feb 10 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 62.07 | 5,840 | 362,489 | 1,723,940 | 1.7 M to 1.7 M (-0.34 %) |
| Feb 10 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 62.20 | 2,686 | 167,069 | 1,729,780 | 1.7 M to 1.7 M (-0.16 %) |
| Feb 10 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 61.40 | 7,314 | 449,080 | 1,732,466 | 1.7 M to 1.7 M (-0.42 %) |
| Feb 10 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.55 | 10,000 | 65,500 | 390,000 | |
| Feb 10 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 5,000 | 31,600 | 0 | |
| Feb 10 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 5,000 | |
| Feb 10 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 63.02 | 7,389 | 465,655 | 0 | 7.4 K to 0 (-100.00 %) |
| Feb 10 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 61.81 | 7,611 | 470,436 | 7,389 | 15 K to 7.4 K (-50.74 %) |
| Feb 10 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 5,000 | 31,600 | 15,000 | 10 K to 15 K (+50.00 %) |
| Feb 10 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.55 | 10,000 | 65,500 | 10,000 | 0 to 10 K |
| Feb 10 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 62.43 | 4,344 | 271,196 | 0 | 4.3 K to 0 (-100.00 %) |
| Feb 10 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 61.96 | 10,656 | 660,246 | 4,344 | 15 K to 4.3 K (-71.04 %) |
| Feb 10 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
| Feb 08 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 20,000 | |
| Feb 08 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 60.12 | 9,850 | 592,182 | 0 | 9.9 K to 0 (-100.00 %) |
| Feb 08 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 59.64 | 5,150 | 307,146 | 9,850 | 15 K to 9.9 K (-34.33 %) |
| Feb 08 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
| Feb 05 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 35,000 | |
| Feb 05 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 50,000 | |
| Feb 05 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 59.25 | 6,695 | 396,679 | 0 | 6.7 K to 0 (-100.00 %) |
| Feb 05 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 58.77 | 8,305 | 488,085 | 6,695 | 15 K to 6.7 K (-55.37 %) |
| Feb 05 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
| Feb 05 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 60.82 | 910 | 55,346 | 0 | 910 to 0 (-100.00 %) |
| Feb 05 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 60.16 | 5,435 | 326,970 | 910 | 6.3 K to 910 (-85.66 %) |
| Feb 05 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 59.39 | 8,655 | 514,020 | 6,345 | 15 K to 6.3 K (-57.70 %) |
| Feb 05 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
| Feb 05 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 7,790 | 49,233 | 186,960 | |
| Feb 05 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 60.34 | 860 | 51,892 | 679 | 1.5 K to 679 (-55.88 %) |
| Feb 05 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 59.49 | 6,930 | 412,266 | 1,539 | 8.5 K to 1.5 K (-81.83 %) |
| Feb 05 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 7,790 | 49,233 | 8,469 | 679 to 8.5 K (+1,147.28 %) |
| Feb 03 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 65,000 | |
| Feb 03 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 80,000 | |
| Feb 03 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 59.99 | 2,010 | 120,580 | 0 | 2 K to 0 (-100.00 %) |
| Feb 03 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 59.20 | 5,280 | 312,576 | 2,010 | 7.3 K to 2 K (-72.43 %) |
| Feb 03 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 58.58 | 7,710 | 451,652 | 7,290 | 15 K to 7.3 K (-51.40 %) |
| Feb 03 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
| Feb 03 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 56.01 | 4,055 | 227,121 | 0 | 4.1 K to 0 (-100.00 %) |
| Feb 03 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 55.36 | 10,945 | 605,915 | 4,055 | 15 K to 4.1 K (-72.97 %) |
| Feb 03 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
| Feb 03 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 7,790 | 49,233 | 194,750 | |
| Feb 03 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 7,790 | 49,233 | 202,540 | |
| Feb 03 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 60.57 | 2,379 | 144,096 | 679 | 3.1 K to 679 (-77.80 %) |
| Feb 03 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 59.80 | 2,501 | 149,560 | 3,058 | 5.6 K to 3.1 K (-44.99 %) |
| Feb 03 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 58.76 | 2,910 | 170,992 | 5,559 | 8.5 K to 5.6 K (-34.36 %) |
| Feb 03 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 7,790 | 49,233 | 8,469 | 679 to 8.5 K (+1,147.28 %) |
| Feb 03 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 56.18 | 3,590 | 201,686 | 679 | 4.3 K to 679 (-84.09 %) |
| Feb 03 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 55.54 | 4,200 | 233,268 | 4,269 | 8.5 K to 4.3 K (-49.59 %) |
| Feb 03 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 7,790 | 49,233 | 8,469 | 679 to 8.5 K (+1,147.28 %) |
| Feb 03 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 7.27 | 1,562 | 11,356 | 35,938 | |
| Feb 03 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.55 | 2,604 | 17,056 | 52,084 | |
| Feb 03 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.55 | 2,604 | 17,056 | 23,438 | |
| Feb 03 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 56.41 | 300 | 16,923 | 0 | 300 to 0 (-100.00 %) |
| Feb 03 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 55.61 | 6,470 | 359,797 | 300 | 6.8 K to 300 (-95.57 %) |
| Feb 03 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 7.27 | 1,562 | 11,356 | 6,770 | 5.2 K to 6.8 K (+29.99 %) |
| Feb 03 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.55 | 2,604 | 17,056 | 5,208 | 2.6 K to 5.2 K (+100.00 %) |
| Feb 03 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.55 | 2,604 | 17,056 | 2,604 | 0 to 2.6 K |
| Feb 01 2021 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Option Exercise | M | 6.55 | 1,771 | 11,600 | 24,792 | |
| Feb 01 2021 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Option Exercise | M | 7.80 | 1,042 | 8,128 | 28,125 | |
| Feb 01 2021 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Sell | S | 57.76 | 628 | 36,273 | 1,300 | 1.9 K to 1.3 K (-32.57 %) |
| Feb 01 2021 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Sell | S | 56.59 | 1,090 | 61,683 | 1,928 | 3 K to 1.9 K (-36.12 %) |
| Feb 01 2021 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Sell | S | 55.71 | 1,095 | 61,002 | 3,018 | 4.1 K to 3 K (-26.62 %) |
| Feb 01 2021 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Buy | M | 6.55 | 1,771 | 11,600 | 4,113 | 2.3 K to 4.1 K (+75.62 %) |
| Feb 01 2021 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Buy | M | 7.80 | 1,042 | 8,128 | 2,342 | 1.3 K to 2.3 K (+80.15 %) |
| Feb 01 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 95,000 | |
| Feb 01 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 57.74 | 1,796 | 103,701 | 0 | 1.8 K to 0 (-100.00 %) |
| Feb 01 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 56.60 | 4,910 | 277,906 | 1,796 | 6.7 K to 1.8 K (-73.22 %) |
| Feb 01 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 55.77 | 8,294 | 462,556 | 6,706 | 15 K to 6.7 K (-55.29 %) |
| Feb 01 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
| Feb 01 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 50,000 | 316,000 | 65,000 | |
| Feb 01 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 50,000 | 316,000 | 115,000 | |
| Feb 01 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 57.70 | 2,184 | 126,017 | 1,000 | 3.2 K to 1,000 (-68.59 %) |
| Feb 01 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 56.68 | 9,704 | 550,023 | 3,184 | 12.9 K to 3.2 K (-75.29 %) |
| Feb 01 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 55.77 | 38,112 | 2,125,506 | 12,888 | 51 K to 12.9 K (-74.73 %) |
| Feb 01 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 50,000 | 316,000 | 51,000 | 1,000 to 51 K (+5,000.00 %) |
| Feb 01 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 57.00 | 18,523 | 1,055,811 | 1,000 | 19.5 K to 1,000 (-94.88 %) |
| Feb 01 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 56.00 | 23,698 | 1,327,088 | 19,523 | 43.2 K to 19.5 K (-54.83 %) |
| Feb 01 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 55.04 | 7,779 | 428,156 | 43,221 | 51 K to 43.2 K (-15.25 %) |
| Feb 01 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 50,000 | 316,000 | 51,000 | 1,000 to 51 K (+5,000.00 %) |